FALVEY MICHAEL 4
4 · Karyopharm Therapeutics Inc. · Filed Jan 25, 2018
Insider Transaction Report
Form 4
FALVEY MICHAEL
EVP, CFO & Treasurer
Transactions
- Award
Stock Option (right to buy)
2018-01-24+95,000→ 95,000 totalExercise: $10.45Exp: 2028-01-23→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 24, 2018. The shares underlying this option vest as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.